Proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 16, Issue 29, 2010, Pages 3664-3673

  Zhang, Lin ^a   Hou, Yan Hong ^a   Wu, Kai ^a   Zhai, Jun Shan ^a   Lin, Nan ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

Differentially expressed proteins; Helicobacter pylori; Proteomic study; Varioliform gastritis

Indexed keywords

BETA ACTIN; NEUROPOLYPEPTIDE H3; PROTEIN TXNDC5; THIOREDOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CYTOSKELETON; DOWN REGULATION; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OXIDATION; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 77955748624     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i29.3664     Document Type: Article

References (35)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64, 1
2. Munoz Monteavaro C, Mendoza D, Palma E. [Varioliform gastritis with "in situ" carcinomatous transformation.] An Fac Med Univ Repub Montev Urug 1960; 45: 72-77
3. Cappell MS, Green PH, Marboe C. Neoplasia in chronic erosive (varioliform) gastritis. Dig Dis Sci 1988; 33: 1035-1039
4. Gallina F, Benedetti-Valentini F. [Varioliform gastritis associated with gastric ulcer simulating a neoplasm.] Riv Gastroenterol 1963; 15: 85-94
5. Vandenborre KM, Ghillebert GL, Rutgeerts LJ, Geboes KR, Rutgeerts PJ, Verbanck JJ, Tanghe WR. Hypertrophic lymphocytic gastritis with a gastric carcinoma. Eur J Gastroenterol Hepatol 1998; 10: 797-801
6. Mosnier JF, Flejou JF, Amouyal G, Gayet B, Molas G, Henin D, Potet F. Hypertrophic gastropathy with gastric adenocarcinoma: Menetrier's disease and lymphocytic gastritis? Gut 1991; 32: 1565-1567
7. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003; 3: 267-275
8. Xing X, Lai M, Gartner W, Xu E, Huang Q, Li H, Chen G. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics 2006; 6: 2916-2923
9. Stulík J, Hernychová L, Porkertová S, Knízek J, Macela A, Bures J, Jandik P, Langridge JI, Jungblut PR. Proteome study of colorectal carcinogenesis. Electrophoresis 2001; 22: 3019-3025
10. Roblick UJ, Hirschberg D, Habermann JK, Palmberg C, Becker S, Krüger S, Gustafsson M, Bruch HP, Franzén B, Ried T, Bergmann T, Auer G, Jörnvall H. Sequential proteome alterations during genesis and progression of colon cancer. Cell Mol Life Sci 2004; 61: 1246-1255
11. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, Minn AJ, Rosner MR. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009; 28: 347-358
12. Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, Bonavida B. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res 2004; 91: 169-200
13. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008; 12: 1275-1287
14. Woods Ignatoski KM, Grewal NK, Markwart SM, Vellaichamy A, Chinnaiyan AM, Yeung K, Ray ME, Keller ET. Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 2008; 72: 153-160
15. Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008; 6: 917-928
16. Biewenga P, Buist MR, Moerland PD, Ver Loren van Themaat E, van Kampen AH, ten Kate FJ, Baas F. Gene expression in early stage cervical cancer. Gynecol Oncol 2008; 108: 520-526
17. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 2007; 127: 820-827
18. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006; 24: 5672-5679
19. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006; 131: 1208-1217
20. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 2006; 16: 451-456
21. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, García JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005; 11: 7392-7397
22. Chatterjee D, Sabo E, Tavares R, Resnick MB. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 2008; 14: 2994-3001
23. Clissold PM, Bicknell R. The thioredoxin-like fold: hidden domains in protein disulfide isomerases and other chaperone proteins. Bioessays 2003; 25: 603-611
24. Sullivan DC, Huminiecki L, Moore JW, Boyle JJ, Poulsom R, Creamer D, Barker J, Bicknell R. EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem 2003; 278: 47079-47088
25. Edman JC, Ellis L, Blacher RW, Roth RA, Rutter WJ. Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 1985; 317: 267-270
26. Freedman RB, Hirst TR, Tuite MF. Protein disulphide isomerase: building bridges in protein folding. Trends Biochem Sci 1994; 19: 331-336
27. Nissom PM, Lo SL, Lo JC, Ong PF, Lim JW, Ou K, Liang RC, Seow TK, Chung MC. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma. FEBS Lett 2006; 580: 2216-2226
28. Fox JG, Wang TC. Helicobacter pylori infection: pathogenesis. Curr Opin Gastroenterol 2002; 18: 15-25
29. Shibata W, Hirata Y, Ogura K, Omata M, Maeda S. [NF-kappaB and MAPK-signaling pathways contribute to the gene expression and host response induced by Helicobacter pylori infection] Nippon Rinsho 2005; 63 Suppl 11: 132-137
30. Lee JS, Kim HS, Hahm KB, Sohn MW, Yoo M, Johnson JA, Surh YJ. Inhibitory effects of 7-carboxymethyloxy-3',4',5- trimethoxyflavone (DA-6034) on Helicobacter pylori-induced NF-kappa B activation and iNOS expression in AGS cells. Ann N Y Acad Sci 2007; 1095: 527-535
31. Kacar F, Meteoǧlu I, Yasa H, Levi E. Helicobacter pyloriinduced changes in the gastric mucosa are associated with mitogen-activated protein kinase (MAPK) activation. Appl Immunohistochem Mol Morphol 2007; 15: 224-228
32. Chen YC, Wang Y, Li JY, Xu WR, Zhang YL. H pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade. World J Gastroenterol 2006; 12: 5972-5977
33. Cam S, Ertem D, Bahceciler N, Akkoc T, Barlan I, Pehlivanoglu E. The interaction between Helicobacter pylori and atopy: does inverse association really exist? Helicobacter 2009; 14: 1-8
34. Shimada M, Ando T, Peek RM, Watanabe O, Ishiguro K, Maeda O, Ishikawa D, Hasegawa M, Ina K, Ohmiya N, Niwa Y, Goto H. Helicobacter pylori infection upregulates interleukin- 18 production from gastric epithelial cells. Eur J Gastroenterol Hepatol 2008; 20: 1144-1150
35. Vivas JR, Regnault B, Michel V, Bussière FI, Avé P, Huerre M, Labigne A, D' Elios MM, Touati E. Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection. Int J Immunopathol Pharmacol 2008; 21: 515-526